APO Research
Talk to an analyst

APO RESEARCH · REPORT

Companion Animal Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Companion Animal Vaccines Industry Growth and Trends Forecast to 2032

19 December 202595 pages

Choose your research edition.

Industry ResearchCompanion Animal Vaccines Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Companion Animal Vaccines Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Companion Animal Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Companion Animal Vaccines Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Companion Animal Vaccines Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Companion Animal Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Companion Animal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Companion Animal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Companion Animal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Companion Animal Vaccines include Merck, Eli Lilly, Bayer, Vetoquinol, Merial, Heska, Ceva and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Companion Animal Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Companion Animal Vaccines market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Companion Animal Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Companion Animal Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Companion Animal Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Companion Animal Vaccines Market by Company

Merck

Eli Lilly

Bayer

Vetoquinol

Merial

Heska

Ceva

Boehringer Ingelheim

Companion Animal Vaccines Segment by Type

Recombinant Vaccines

Subunit Vaccines

Inactivated Vaccines

Toxoid Vaccines

Conjugate Vaccines

Attenuated Live Vaccines

DNA Vaccines

Companion Animal Vaccines Segment by Application

Canine

Avian

Feline

Companion Animal Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Companion Animal Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Companion Animal Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Companion Animal Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Companion Animal Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Companion Animal Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Recombinant Vaccines Table 2. Major Company of Subunit Vaccines Table 3. Major Company of Inactivated Vaccines Table 4. Major Company of Toxoid Vaccines Table 5. Major Company of Conjugate Vaccines Table 6. Major Company of Attenuated Live Vaccines Table 7. Major Company of DNA Vaccines Table 8. Global Companion Animal Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Companion Animal Vaccines Sales by Type (2021-2026) & (W Units) Table 10. Global Companion Animal Vaccines Sales Market Share in Volume by Type (2021-2026) Table 11. Global Companion Animal Vaccines Sales by Type (2021-2026) & (US$ Million) Table 12. Global Companion Animal Vaccines Sales Market Share in Value by Type (2021-2026) Table 13. Global Companion Animal Vaccines Price by Type (2021-2026) & (US$/Unit) Table 14. Global Companion Animal Vaccines Sales by Type (2027-2032) & (W Units) Table 15. Global Companion Animal Vaccines Sales Market Share in Volume by Type (2027-2032) Table 16. Global Companion Animal Vaccines Sales by Type (2027-2032) & (US$ Million) Table 17. Global Companion Animal Vaccines Sales Market Share in Value by Type (2027-2032) Table 18. Global Companion Animal Vaccines Price by Type (2027-2032) & (US$/Unit) Table 19. North America Companion Animal Vaccines Sales by Type (2021-2026) & (W Units) Table 20. North America Companion Animal Vaccines Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Companion Animal Vaccines Sales by Type (2021-2026) & (W Units) Table 22. Europe Companion Animal Vaccines Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Companion Animal Vaccines Sales by Type (2021-2026) & (W Units) Table 24. Asia-Pacific Companion Animal Vaccines Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Companion Animal Vaccines Sales by Type (2021-2026) & (W Units) Table 26. Latin America Companion Animal Vaccines Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Companion Animal Vaccines Sales by Type (2021-2026) & (W Units) Table 28. Middle East and Africa Companion Animal Vaccines Sales by Type (2021-2026) & (US$ Million) Table 29. Companion Animal Vaccines Industry Trends Table 30. Companion Animal Vaccines Industry Drivers Table 31. Companion Animal Vaccines Industry Opportunities and Challenges Table 32. Companion Animal Vaccines Industry Restraints Table 33. Global Companion Animal Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Companion Animal Vaccines Revenue Market Share by Company (2021-2026) Table 35. Global Companion Animal Vaccines Sales by Company (2021-2026) & (W Units) Table 36. Global Companion Animal Vaccines Sales Share by Company (2021-2026) Table 37. Global Companion Animal Vaccines Market Price by Company (2021-2026) & (US$/Unit) Table 38. Global Companion Animal Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Companion Animal Vaccines Major Company Production Sites and Headquarters Table 40. Global Companion Animal Vaccines Company, Product Type & Application Table 41. Global Companion Animal Vaccines Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Companion Animal Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Companion Animal Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Companion Animal Vaccines Sales by Region (2021-2026) & (W Units) Table 46. Global Companion Animal Vaccines Sales Market Share in Volume by Region (2021-2026) Table 47. Global Companion Animal Vaccines Sales by Region (2021-2026) & (US$ Million) Table 48. Global Companion Animal Vaccines Sales Market Share in Value by Region (2021-2026) Table 49. Global Companion Animal Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 50. Global Companion Animal Vaccines Sales by Region (2027-2032) & (W Units) Table 51. Global Companion Animal Vaccines Sales Market Share in Volume by Region (2027-2032) Table 52. Global Companion Animal Vaccines Sales by Region (2027-2032) & (US$ Million) Table 53. Global Companion Animal Vaccines Sales Market Share in Value by Region (2027-2032) Table 54. Global Companion Animal Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 55. Global Companion Animal Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Companion Animal Vaccines Sales by Application (2021-2026) & (W Units) Table 57. Global Companion Animal Vaccines Sales Market Share in Volume by Application (2021-2026) Table 58. Global Companion Animal Vaccines Sales by Application (2021-2026) & (US$ Million) Table 59. Global Companion Animal Vaccines Sales Market Share in Value by Application (2021-2026) Table 60. Global Companion Animal Vaccines Price by Application (2021-2026) & (US$/Unit) Table 61. Global Companion Animal Vaccines Sales by Application (2027-2032) & (W Units) Table 62. Global Companion Animal Vaccines Sales Market Share in Volume by Application (2027-2032) Table 63. Global Companion Animal Vaccines Sales by Application (2027-2032) & (US$ Million) Table 64. Global Companion Animal Vaccines Sales Market Share in Value by Application (2027-2032) Table 65. Global Companion Animal Vaccines Price by Application (2027-2032) & (US$/Unit) Table 66. North America Companion Animal Vaccines Sales by Application (2021-2026) & (W Units) Table 67. North America Companion Animal Vaccines Sales by Application (2021-2026) & (US$ Million) Table 68. Europe Companion Animal Vaccines Sales by Application (2021-2026) & (W Units) Table 69. Europe Companion Animal Vaccines Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific Companion Animal Vaccines Sales by Application (2021-2026) & (W Units) Table 71. Asia-Pacific Companion Animal Vaccines Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America Companion Animal Vaccines Sales by Application (2021-2026) & (W Units) Table 73. Latin America Companion Animal Vaccines Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa Companion Animal Vaccines Sales by Application (2021-2026) & (W Units) Table 75. Middle East and Africa Companion Animal Vaccines Sales by Application (2021-2026) & (US$ Million) Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck Companion Animal Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Merck Companion Animal Vaccines Product Portfolio Table 80. Merck Recent Development Table 81. Eli Lilly Company Information Table 82. Eli Lilly Business Overview Table 83. Eli Lilly Companion Animal Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Eli Lilly Companion Animal Vaccines Product Portfolio Table 85. Eli Lilly Recent Development Table 86. Bayer Company Information Table 87. Bayer Business Overview Table 88. Bayer Companion Animal Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Bayer Companion Animal Vaccines Product Portfolio Table 90. Bayer Recent Development Table 91. Vetoquinol Company Information Table 92. Vetoquinol Business Overview Table 93. Vetoquinol Companion Animal Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Vetoquinol Companion Animal Vaccines Product Portfolio Table 95. Vetoquinol Recent Development Table 96. Merial Company Information Table 97. Merial Business Overview Table 98. Merial Companion Animal Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Merial Companion Animal Vaccines Product Portfolio Table 100. Merial Recent Development Table 101. Heska Company Information Table 102. Heska Business Overview Table 103. Heska Companion Animal Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Heska Companion Animal Vaccines Product Portfolio Table 105. Heska Recent Development Table 106. Ceva Company Information Table 107. Ceva Business Overview Table 108. Ceva Companion Animal Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Ceva Companion Animal Vaccines Product Portfolio Table 110. Ceva Recent Development Table 111. Boehringer Ingelheim Company Information Table 112. Boehringer Ingelheim Business Overview Table 113. Boehringer Ingelheim Companion Animal Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Boehringer Ingelheim Companion Animal Vaccines Product Portfolio Table 115. Boehringer Ingelheim Recent Development Table 116. North America Companion Animal Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 117. North America Companion Animal Vaccines Sales by Country (2021-2026) & (W Units) Table 118. North America Companion Animal Vaccines Sales Market Share by Country (2021-2026) Table 119. North America Companion Animal Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 120. North America Companion Animal Vaccines Sales Market Share Forecast by Country (2027-2032) Table 121. North America Companion Animal Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Companion Animal Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Companion Animal Vaccines Market Share by Country (2021-2026) Table 124. North America Companion Animal Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Companion Animal Vaccines Market Share Forecast by Country (2027-2032) Table 126. Europe Companion Animal Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 127. Europe Companion Animal Vaccines Sales by Country (2021-2026) & (W Units) Table 128. Europe Companion Animal Vaccines Sales Market Share by Country (2021-2026) Table 129. Europe Companion Animal Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 130. Europe Companion Animal Vaccines Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Companion Animal Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Companion Animal Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Companion Animal Vaccines Market Share by Country (2021-2026) Table 134. Europe Companion Animal Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Companion Animal Vaccines Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Companion Animal Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Companion Animal Vaccines Sales by Country (2021-2026) & (W Units) Table 138. Asia-Pacific Companion Animal Vaccines Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Companion Animal Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 140. Asia-Pacific Companion Animal Vaccines Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Companion Animal Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Companion Animal Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Companion Animal Vaccines Market Share by Country (2021-2026) Table 144. Asia-Pacific Companion Animal Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Companion Animal Vaccines Market Share Forecast by Country (2027-2032) Table 146. Latin America Companion Animal Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 147. Latin America Companion Animal Vaccines Sales by Country (2021-2026) & (W Units) Table 148. Latin America Companion Animal Vaccines Sales Market Share by Country (2021-2026) Table 149. Latin America Companion Animal Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 150. Latin America Companion Animal Vaccines Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Companion Animal Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Companion Animal Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Companion Animal Vaccines Market Share by Country (2021-2026) Table 154. Latin America Companion Animal Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Companion Animal Vaccines Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Companion Animal Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Companion Animal Vaccines Sales by Country (2021-2026) & (W Units) Table 158. Middle East and Africa Companion Animal Vaccines Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Companion Animal Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 160. Middle East and Africa Companion Animal Vaccines Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Companion Animal Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Companion Animal Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Companion Animal Vaccines Market Share by Country (2021-2026) Table 164. Middle East and Africa Companion Animal Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Companion Animal Vaccines Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Companion Animal Vaccines Distributors List Table 169. Companion Animal Vaccines Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Companion Animal Vaccines Image Figure 2. Global Companion Animal Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Companion Animal Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Companion Animal Vaccines Sales (2021-2032) & (W Units) Figure 5. Recombinant Vaccines Image Figure 6. Global Recombinant Vaccines Sales YoY Growth (2021-2032) & (W Units) Figure 7. Subunit Vaccines Image Figure 8. Global Subunit Vaccines Sales YoY Growth (2021-2032) & (W Units) Figure 9. Inactivated Vaccines Image Figure 10. Global Inactivated Vaccines Sales YoY Growth (2021-2032) & (W Units) Figure 11. Toxoid Vaccines Image Figure 12. Global Toxoid Vaccines Sales YoY Growth (2021-2032) & (W Units) Figure 13. Conjugate Vaccines Image Figure 14. Global Conjugate Vaccines Sales YoY Growth (2021-2032) & (W Units) Figure 15. Attenuated Live Vaccines Image Figure 16. Global Attenuated Live Vaccines Sales YoY Growth (2021-2032) & (W Units) Figure 17. DNA Vaccines Image Figure 18. Global DNA Vaccines Sales YoY Growth (2021-2032) & (W Units) Figure 19. Global Companion Animal Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Companion Animal Vaccines Market Share by Type 2025 VS 2032 Figure 21. North America Companion Animal Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. North America Companion Animal Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Europe Companion Animal Vaccines Sales Market Share in Volume by Type in 2025 Figure 24. Europe Companion Animal Vaccines Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Companion Animal Vaccines Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Companion Animal Vaccines Sales Market Share in Value by Type in 2025 Figure 27. Latin America Companion Animal Vaccines Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Companion Animal Vaccines Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Companion Animal Vaccines Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Companion Animal Vaccines Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Companion Animal Vaccines Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Canine Image Figure 34. Global Canine Sales YoY Growth (2021-2032) & (W Units) Figure 35. Avian Image Figure 36. Global Avian Sales YoY Growth (2021-2032) & (W Units) Figure 37. Feline Image Figure 38. Global Feline Sales YoY Growth (2021-2032) & (W Units) Figure 39. Global Companion Animal Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Companion Animal Vaccines Market Share by Application 2025 VS 2032 Figure 41. North America Companion Animal Vaccines Sales Market Share in Volume by Application in 2025 Figure 42. North America Companion Animal Vaccines Sales Market Share in Value by Application in 2025 Figure 43. Europe Companion Animal Vaccines Sales Market Share in Volume by Application in 2025 Figure 44. Europe Companion Animal Vaccines Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Companion Animal Vaccines Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Companion Animal Vaccines Sales Market Share in Value by Application in 2025 Figure 47. Latin America Companion Animal Vaccines Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Companion Animal Vaccines Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Companion Animal Vaccines Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Companion Animal Vaccines Sales Market Share in Value by Application in 2025 Figure 51. North America Companion Animal Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. North America Companion Animal Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Companion Animal Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Companion Animal Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Companion Animal Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Europe Companion Animal Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Companion Animal Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Companion Animal Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Companion Animal Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Asia-Pacific Companion Animal Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Companion Animal Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Companion Animal Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Companion Animal Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Latin America Companion Animal Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Companion Animal Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Companion Animal Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Companion Animal Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 68. Middle East and Africa Companion Animal Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Companion Animal Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Companion Animal Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Companion Animal Vaccines Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Companion Animal Vaccines Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Vaccines
  • Subunit Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Conjugate Vaccines
  • Attenuated Live Vaccines
  • DNA Vaccines
Applications
  • Canine
  • Avian
  • Feline
Companies covered
  • Merck
  • Eli Lilly
  • Bayer
  • Vetoquinol
  • Merial
  • Heska
  • Ceva
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Companion Animal Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Companion Animal Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Companion Animal Vaccines Market by Type
  6. 1.3.1 Recombinant Vaccines
  7. 1.3.2 Subunit Vaccines
  8. 1.3.3 Inactivated Vaccines
  9. 1.3.4 Toxoid Vaccines
  10. 1.3.5 Conjugate Vaccines
  11. 1.3.6 Attenuated Live Vaccines
  12. 1.3.7 DNA Vaccines
  13. 1.4 Global Companion Animal Vaccines Market Size by Type
  14. 1.4.1 Global Companion Animal Vaccines Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Companion Animal Vaccines Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Companion Animal Vaccines Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Companion Animal Vaccines Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Companion Animal Vaccines Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Companion Animal Vaccines Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Companion Animal Vaccines Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Companion Animal Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Companion Animal Vaccines Industry Trends
  2. 2.2 Companion Animal Vaccines Industry Drivers
  3. 2.3 Companion Animal Vaccines Industry Opportunities and Challenges
  4. 2.4 Companion Animal Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Companion Animal Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Companion Animal Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Companion Animal Vaccines Price (2021-2026)
  4. 3.4 Global Companion Animal Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Companion Animal Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Companion Animal Vaccines Company, Product Type & Application
  7. 3.7 Global Companion Animal Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Companion Animal Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Companion Animal Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Companion Animal Vaccines Tier 1, Tier 2, and Tier 3
4 Companion Animal Vaccines Regional Status and Outlook
  1. 4.1 Global Companion Animal Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Companion Animal Vaccines Historic Market Size by Region
  3. 4.2.1 Global Companion Animal Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Companion Animal Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Companion Animal Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Companion Animal Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Companion Animal Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Companion Animal Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Companion Animal Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Companion Animal Vaccines by Application
  1. 5.1 Companion Animal Vaccines Market by Application
  2. 5.1.1 Canine
  3. 5.1.2 Avian
  4. 5.1.3 Feline
  5. 5.2 Global Companion Animal Vaccines Market Size by Application
  6. 5.2.1 Global Companion Animal Vaccines Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Companion Animal Vaccines Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Companion Animal Vaccines Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Companion Animal Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Companion Animal Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Companion Animal Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Companion Animal Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Companion Animal Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Companion Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Companion Animal Vaccines Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 Eli Lilly
  8. 6.2.1 Eli Lilly Company Information
  9. 6.2.2 Eli Lilly Business Overview
  10. 6.2.3 Eli Lilly Companion Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eli Lilly Companion Animal Vaccines Product Portfolio
  12. 6.2.5 Eli Lilly Recent Developments
  13. 6.3 Bayer
  14. 6.3.1 Bayer Company Information
  15. 6.3.2 Bayer Business Overview
  16. 6.3.3 Bayer Companion Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bayer Companion Animal Vaccines Product Portfolio
  18. 6.3.5 Bayer Recent Developments
  19. 6.4 Vetoquinol
  20. 6.4.1 Vetoquinol Company Information
  21. 6.4.2 Vetoquinol Business Overview
  22. 6.4.3 Vetoquinol Companion Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Vetoquinol Companion Animal Vaccines Product Portfolio
  24. 6.4.5 Vetoquinol Recent Developments
  25. 6.5 Merial
  26. 6.5.1 Merial Company Information
  27. 6.5.2 Merial Business Overview
  28. 6.5.3 Merial Companion Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merial Companion Animal Vaccines Product Portfolio
  30. 6.5.5 Merial Recent Developments
  31. 6.6 Heska
  32. 6.6.1 Heska Company Information
  33. 6.6.2 Heska Business Overview
  34. 6.6.3 Heska Companion Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Heska Companion Animal Vaccines Product Portfolio
  36. 6.6.5 Heska Recent Developments
  37. 6.7 Ceva
  38. 6.7.1 Ceva Company Information
  39. 6.7.2 Ceva Business Overview
  40. 6.7.3 Ceva Companion Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Ceva Companion Animal Vaccines Product Portfolio
  42. 6.7.5 Ceva Recent Developments
  43. 6.8 Boehringer Ingelheim
  44. 6.8.1 Boehringer Ingelheim Company Information
  45. 6.8.2 Boehringer Ingelheim Business Overview
  46. 6.8.3 Boehringer Ingelheim Companion Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Boehringer Ingelheim Companion Animal Vaccines Product Portfolio
  48. 6.8.5 Boehringer Ingelheim Recent Developments
7 North America by Country
  1. 7.1 North America Companion Animal Vaccines Sales by Country
  2. 7.1.1 North America Companion Animal Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Companion Animal Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Companion Animal Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Companion Animal Vaccines Market Size by Country
  6. 7.2.1 North America Companion Animal Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Companion Animal Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Companion Animal Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Companion Animal Vaccines Sales by Country
  2. 8.1.1 Europe Companion Animal Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Companion Animal Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Companion Animal Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Companion Animal Vaccines Market Size by Country
  6. 8.2.1 Europe Companion Animal Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Companion Animal Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Companion Animal Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Companion Animal Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Companion Animal Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Companion Animal Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Companion Animal Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Companion Animal Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Companion Animal Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Companion Animal Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Companion Animal Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Companion Animal Vaccines Sales by Country
  2. 10.1.1 South America Companion Animal Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Companion Animal Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Companion Animal Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Companion Animal Vaccines Market Size by Country
  6. 10.2.1 South America Companion Animal Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Companion Animal Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Companion Animal Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Companion Animal Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Companion Animal Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Companion Animal Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Companion Animal Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Companion Animal Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Companion Animal Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Companion Animal Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Companion Animal Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Companion Animal Vaccines Value Chain Analysis
  2. 12.1.1 Companion Animal Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Companion Animal Vaccines Production Mode & Process
  7. 12.2 Companion Animal Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Companion Animal Vaccines Distributors
  10. 12.2.3 Companion Animal Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst